Q4 2025 Earnings Call February 26, 2026 10:00 AM ESTCompany ParticipantsEric Micek - Vice President of Investor RelationsJames Burke ...
Objective To assess whether post-authorisation studies registered with the European Medicines Agency (EMA) adhere to legislation and recommendations to publicly post study protocols and results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results